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A large body of literature supports cognitive enhancement as an effect of cholinergic
potentiation. However, it remains elusive whether pharmacological manipulations of
cholinergic neurotransmission enhance complex visual processing in healthy individuals.
To test this hypothesis, we randomly administered either the cholinergic transmission
enhancer donepezil (DPZ; 5 mg P.O.) or placebo (lactose) to young adults (n = 17)
3 h before each session of the three-dimensional (3D) multiple object tracking
(3D-MOT) task. This multi-focal attention task evaluates perceptual-cognitive learning
over five sessions conducted 7 days apart. A significant amount of learning was
observed in the DPZ group but not the placebo group in the fourth session. In the
fifth session, this learning effect was observed in both groups. Furthermore, preliminary
results for a subgroup of participants (n = 9) 4–14 months later suggested the cholinergic
enhancement effect was long lasting. On the other hand, DPZ had no effect on basic
visual processing as measured by a motion and orientation discrimination task performed
as an independent one-time, pre-post drug study without placebo control (n = 10). The
results support the construct that cholinergic enhancement facilitates the encoding of
a highly demanding perceptual-cognitive task although there were no significant drug
effects on the performance levels compared to placebo.
Keywords: 3D-multiple object tracking/NeuroTracker, acetylcholine, acetylcholinesterase inhibitor, attention,
cognitive enhancer, donepezil, sensory training, visual learning
INTRODUCTION
Sensory training has recently emerged as a promising field in the improvement of perception and
cognition (Seitz, 2010). The enhancement of perception and cognition would alleviate sensory
shift due to aging or sensory diseases or simply improve daily and sport-related performance.
Various training procedures, such as the repetitive presentation of a specific set of stimuli, have been
proposed for computer, tablet or three-dimensional (3D) environment (Faubert and Sidebottom,
2012; Kim et al., 2015). Moreover, recent evidence shows that stimulation of the neuromodulatory
brain systems may potentiate perceptual learning (long-term improvement of perception induced
by sensory training; Rokem and Silver, 2010; Kang et al., 2015).
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It has been shown that the cholinergic system improves the
efficiency of cortical processing of visual stimuli. Acetylcholine
(ACh) optimizes the gain of pyramidal cells in response to
sensory stimuli and reduces sensory noise in humans (Moran
et al., 2013). This contributes to visual attention and learning
processes (Yu and Dayan, 2002; Sarter et al., 2005; Hasselmo,
2006; Herrero et al., 2008). This also increases both sensory
precision and the strength of the representation of stimuli.
Moreover, in cases of visual training it has been shown that ACh
aids cortical processing, improving both its speed and efficiency
(Ricciardi et al., 2013). Therefore, combining visual training
of a specific stimulus with cholinergic potentiation, namely
electrical or pharmacological stimulation of the cholinergic
system, induces enhancement of visual perceptual learning
(Rokem and Silver, 2010; Beer et al., 2013; Kang et al.,
2014a,b).
Animal studies investigating electrical stimulation of
cholinergic neurons paired with visual stimulation demonstrate
a strong effect on cortical responses in the primary visual
cortex (V1), cortical plasticity and visual performance (Goard
and Dan, 2009; Kang and Vaucher, 2009; Bhattacharyya et al.,
2013; Kang et al., 2014a). However, there are certain issues
with implementing this electrical stimulation technique in
a human clinical setting. A worthwhile alternative to this
cholinergic enhancement is the use of acetylcholinesterase
inhibitors (AChEIs), drugs used in Alzheimer’s disease to block
the breakdown of ACh at the synapse and prolong its action.
Accordingly, AChEIs improve performance of people in visual
attention tasks (Demeter and Sarter, 2013) and behavioral tasks
that require voluntary attention (Bentley et al., 2004). In rats,
donepezil (DPZ), the AChEI most universally used for the
clinical treatment of Alzheimer’s disease, has been demonstrated
to increase the amplitude of visually evoked potentials when
administered during a visual training period (Chamoun et al.,
2016). DPZ also improves performance in diverse cognitive
behavioral tasks (Wise et al., 2007; Cutuli et al., 2008; Soma et al.,
2013). Pharmacological therapy with AChEIs combined with
a behavioral intervention is therefore a potentially interesting
therapeutic approach to enhancing perceptual-cognitive visual
performance in humans.
Therefore, we used the 3D-multiple object tracking (3D-
MOT) task to evaluate the effect of cholinergic potentiation
on the perceptual-cognitive capacity of healthy young adults.
In the 3D-MOT test, tracking of several targets among
distractors is done in a 3D environment to increase stereoscopy
and demands on attention tracking (Parsons et al., 2016).
3D-MOT thus entails multi-focal attention and requires a
high level of processing (Pylyshyn and Storm, 1988; Cavanagh
and Alvarez, 2005; Faubert and Sidebottom, 2012; Legault
and Faubert, 2012) which encompasses the capacity of the
brain to ignore distractors and noise. The task is performed
weekly over 5 weeks (a 30-min session once a week). A
significant increase in tracking performance is usually measured
during the fifth session. 3D-MOT is usually used to improve
vision in athletes (Faubert, 2013) and aging persons (Legault
and Faubert, 2012; Legault et al., 2013). Since 3D-MOT
requires a high attentional load and induces perceptual and
cognitive learning, it falls into the range of possible cholinergic
involvement and thus should be sensitive to cholinergic
potentiation.
We therefore administered DPZ during 3D-MOT perceptual-
cognitive training and calculated speed thresholds for tracking
moving balls. Moreover, the acute effect of DPZ on basic visual
processing was further evaluated with orientation and visual
motion discrimination (Hutchinson and Ledgeway, 2006; Allard
and Faubert, 2013). We demonstrated that the tracking ability
was improved at an earlier time point in healthy young adults
taking DPZ, which could be related to attention and efficiency
of cortical processing. Moreover, preliminary data suggest a
long-lasting effect on performance. This study supports the
possibility of using DPZ to improve training of perceptual-
cognitive function in humans.
MATERIALS AND METHODS
General Methods
Participants
Twenty healthy young adults participated in the study. Two
participants were excluded due to a time conflict, and one
was excluded due to unsatisfactory baseline performance. The
participants (10 men, 7 women; age: 23 ± 1 years; body mass
index, BMI: 23 ± 1 kg/m2, mean ± SEM, see Table 1) were
randomly assigned to either the DPZ (n = 9) or placebo
(lactose pills, n = 8) group. Only some participants were
available to perform long-term 3D-MOT task testing (Table 1).
Ten participants were independently tested with motion or
orientation discrimination tasks (more than 6 months after the
3D-MOT task) using a cross-over design experiment (see Table 1
and below). The sample size (n = 10 per group) was determined
TABLE 1 | Demographic data: participant characteristics and involvement in the three-dimensional (3D)-MOT task and basic visual discrimination tasks.
Participant n Age years Height cm Weight kg BMI kg/m2
MOT 17 23 ± 1 (20–31) 173 ± 3 (157–193) 69 ± 3 (47–95) 22 ± 1 (19–26)
DPZ group 9 22 ± 1 (20–26) 176 ± 3 (167–193) 71 ± 4 (56–90) 22 ± 1 (19–26)
Placebo 8 24 ± 1 (20–31) 169 ± 4 (157–192) 67 ± 6 (47–95) 23 ± 1 (19–25)
MOT, long-term 9 24 ± 1 (20–31) 173 ± 3 (159–193) 70 ± 4 (50–90) 23 ± 1 (19–25)
Visual discrimination 10 23 ± 1 (20–27) 174 ± 2 (167–193) 69 ± 3 (68–90) 23 ± 1 (19–25)
Values represent the mean ± SEM (range) of participants in the MOT task, long-term MOT testing and basic motion and orientation discrimination tasks (Visual
discrimination). Only a subset of participants could participate in the long-term MOT retesting and visual discrimination task. BMI, body mass index; MOT, multiple
object tracking.
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TABLE 2 | Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Aged 20–35 Previous MOT task participant
Good health Attention deficit
Body mass index between 17 and 26 Smoker
No visual impairment or ocular pathology not
corrected by glasses or contact lenses
Pregnant, breast feeding or
planning a pregnancy
Good 3D vision Lactose intolerance
based on previous studies on the 3D-MOT task (Legault et al.,
2013) and visual perception tasks (Allard and Faubert, 2013).
All participants were naive to the purpose of the experiment
and met the inclusion and exclusion criteria (Table 2): normal
or corrected-to-normal vision, no history of neurological,
psychiatric or toxicological problems, no history of smoking,
etc. BMI measurements had to be 17–26 kg/m2 in order to
ascertain a similar distribution of the drug across subjects. A
standard clinical and neurological examination, a stereoacuity
test and an ECG recording were performed before the
beginning of the experiment. All participants completed a
written informed consent form prior to the beginning of
the experiment. All data were collected and kept secured in
the laboratory of Drs. Vaucher and Faubert at the School
of Optometry. The participants were enrolled by the student
researcher, MC, and their random allocation sequence was
carried out by EV by assigning drug/placebo in numbered
containers. Numbers were assigned to participants in order of
participation. Subjects received financial compensation to cover
travel expenses and time spent participating in the experiment.
The procedures were in accordance with theHelsinki Declaration
of 2013 and the ethical standards of the Comité d’éthique de
la recherche en santé, Université de Montréal, approval #12-
084-CERES-P. The study was registered on ClinicalTrials.gov
(NCT01738295).
Donepezil Pharmacological Enhancement
DPZ is a reversible, non-competitive, highly selective AChEI
with a half-life of 80 h and a peak plasma level of 4.1 ± 1.5 h
after intake (Rogers and Friedhoff, 1998). The 5 mg dose
was selected because it is the lowest prescribed dose which
induces beneficial cognitive effects with very low adverse
reaction incidence (Prvulovic and Schneider, 2014). This
dose has been shown to be effective in improving visual
attention and neural plasticity in young adults (Rokem and
Silver, 2010; Rokem et al., 2010). Three hours before each
session, subjects were administered one capsule containing
either 5 mg DPZ (ARICEPTr, Pfizer, Canada) or lactose
placebo with water (Rokem and Silver, 2010). The experimenter
and subjects were naive to the experimental conditions. We
used commercially available DPZ tablets (ARICEPTr, Pfizer,
Canada) but this company has no financial interest in this
study.
Experiment 1: 3D-Multiple Object Tracking
The goal of this experiment was to determine if acute
administration of DPZ at each weekly session of the 3D-MOT
task over five consecutive sessions could improve the tracking
of four objects either in terms of performance threshold or
learning rate. An additional test of the 3D-MOT task was
carried out with the available participants 4–14 months after
the end of training without drug intake (n = 5, DPZ group;
n = 4, control group, nine participants from the original 17,
see Table 1) to assess the preliminary results of the long-lasting
effect of cholinergic enhancement on this perceptual-cognitive
task.
Experimental Design
All subjects were tested on the 3D-MOT task once a week for
five consecutive weeks. The first week was used as a baseline
measurement and was done without administering the drug or
placebo. This was a double-blind placebo controlled intervention.
The study drug or placebo was administered P.O. 3 h before the
testing for the next 4 weeks.
Procedure
The task consisted of eight yellow spheres projected in the
Cave Automatic Virtual Environment (CAVE). The CAVE
is a fully immersive virtual environment consisting of an
8 × 8 × 8 foot room that includes three canvas walls (one
frontal and two lateral walls) and an epoxy floor that serve as
the surface for image projection (Figure 1A). Each participant
sat 177 cm from the central wall of the CAVE with eye
height set at 160 cm from the ground. They were asked
to wear stereoscopic goggles to visualize the 3D-environment
and to fixate on a point located straight ahead of them.
Four of the balls turned orange for identification. Then all
spheres turned back to yellow and followed a linear trajectory
with a selected speed. The spheres moved in a 3D-volume
space, sometimes bouncing off of or occluding one another
or bouncing off the virtual wall (Figure 1A). This movement
activity lasted 8 s and then stopped. Next, participants had to
identify the target spheres. They received feedback as to their
correct or incorrect response. The next speed was determined
using a 1-up-1-down staircase procedure (Levitt, 1971; Legault
et al., 2013). The staircase was interrupted after eight reversals.
The speed thresholds were established from the mean of the
last four staircase reversals. Each testing session consisted of
three repetitions of the same block, each of which lasted
approximately 10 min.
Experimental Setting
As previously described (Legault et al., 2013), four
high-resolution projectors were synchronized and the image was
updated in real-time to maintain the observer’s true viewing
perspective (i.e., no false parallax). A magnetic motion tracker
system (Flock-of-Birds) was used to measure head position,
which was used to correct the viewing perspective of the
observer in real-time. The CAVE was under the control of
a SGI ONYX 3200 computer (two Infinite Reality 2 graphic
cards), which produced a stereoscopic environment. The
stereoscopy was generated with Crystal Eyes 2 active shutter
glasses synchronized at 96 Hz (48 Hz per eye). Before testing,
subjects were familiarized with the virtual environment and
stimuli.
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FIGURE 1 | Three-dimensional (3D)-multiple object tracking (3D-MOT) task: comparison of tracking performance in the donepezil (DPZ) and placebo
group. (A) Example of the 3D-MOT: eight yellow spheres are randomly positioned in a virtual 3D environment; four randomly selected spheres turn orange for
identification of the spheres to track (targets); then all spheres turn back to yellow and move following a random linear trajectory (arrows represent initial movement)
at a defined speed; the spheres stop, are numbered and the participant identifies the targets (orange border); finally, the targets turn orange for correct feedback; the
targets turn yellow with a red border for a wrong answer and the targets turn light orange for a right answer not identified. The trial is then repeated, changing the
speed of the movement of the spheres using a 1-up-1-down staircase procedure. The speed threshold for which the subjects are able to track balls is calculated
from the mean of the last four reversals of the staircase. (B) Tracking performance in terms of speed threshold (cm/s) for each participant every testing week (Weeks
1–5) in the control group (blue-shaded squares) and DPZ group (purple-shaded circles). The mean of the speed threshold (gray bar) is given. (C) Speed threshold
(percent change from baseline) for tracking performance of subjects every testing week and during long-term testing (4–14 months after the initial training) for the
control group (in blue) and the DPZ group (in purple). (D) The significance table represents (a) the statistical comparison of the mean speed threshold for each group
using Friedman’s test with Bonferroni correction (upper panel). Note that the DPZ group significantly improved their performance (significant difference in speed
threshold compared to baseline value) at Weeks 4 and 5, while the control group only reached this level of improvement at Week 5; (b) the statistical comparison of
the mean speed threshold of long-term testing to baseline values using the Wilcoxon test. There was a significant sustained improvement in the speed threshold in
the DPZ group but not in the control group. ∗Significantly different compared to baseline (week 1), p < 0.05.
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Experiment 2: Orientation and Motion
Visual Perception
The goal of this experiment was to test whether DPZ alters
basic visual processing, tested in a motion and orientation
discrimination task. This task was tested independently from the
3D-MOT task (at least 6 months after the last drug intake).
Experimental Design
Ten healthy young adults (6 men, 4 women; age: 24 ± 1 years;
BMI: 23 ± 1 kg/m2; mean ± SEM, nine participants from the
original 17 and 1 new participant; see Table 1) took part in a
pre-post drug study without placebo control. All subjects were
tested on the orientation and motion visual perception task once
before and 3 h after receiving DPZ at the peak DPZ plasma
concentration. However, the subjects were told that they could
receive either placebo or DPZ.
Procedure
The task was performed as previously designed and validated
(Allard and Faubert, 2013). The observer was positioned in
a dark room 114 cm from the display and familiarized with
the task. A trial consisted of identifying the motion or the
orientation of a sine-wave grating of 0.3 CPD, by pushing arrow
keys on a keyboard (Figure 2A). A feedback sound indicated
whether the response was correct or incorrect. Motion stimuli
were composed of either a luminance or a contrast modulation
of a sine-wave grating drifting in a random direction (either
left or right). All modulations were vertically oriented. First-
order motion stimulus (luminance modulation) drifted at 15 Hz
and the second-order motion stimulus (contrast modulation) at
2 Hz. The orientation task was a horizontal or vertical display
of the sine-wave grating. The contrast or luminance modulation
was controlled by a 2-down-1-up staircase procedure (Levitt,
1971; Allard and Faubert, 2008a) and the luminance or contrast
threshold obtained for the stimulus discrimination was estimated
for the last six reversals of the staircase. The testing consisted of
three repetitions of four blocks of trials; each block presented
one of the four conditions (first- and second-order motion and
first-and second-order orientation) in a randomized manner.
The testing duration was approximately 30 min.
FIGURE 2 | Motion and orientation discrimination: acute effect of a one-time administration of DPZ. (A) Representation of the basic visual perception tasks
of motion (upper panel) and orientation (lower panel) discrimination of the stimulus. The stimulus is a sine-wave grating of 0.3 cycles per degree modulated by
discrete variations of luminance, first-order luminance defined stimulus (left panel) or contrast, second-order contrast defined stimulus (right panel). Average
Michelson contrast thresholds are shown for luminance-defined stimulus (B) for the discrimination of motion (left) or orientation (right) before (open bar) and 3 h after
(black bar) DPZ intake, and for the contrast-defined stimulus (C) for the discrimination of motion (left) or orientation (right) before (open bar) and 3 h after (black bar)
DPZ intake. For both the motion and the orientation discrimination tasks, neither the mean luminance modulation threshold nor the mean contrast modulation
thresholds reached by the participants were altered by the intake of DPZ (Wilcoxon test, p > 0.05). Error bars represent SEM values.
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Experimental Setting
Stimuli were presented on a gamma-linearized 22′′ Formac
ProNitron 22800 CRT monitor with a mean luminance of
42 cd/m2 and a refresh rate set at 120 Hz. The spatial window
was circular with a diameter of 4◦. The presentation time was
500 ms. The noisy-bit method (Allard and Faubert, 2008b) was
implemented to improve the screen luminance resolution and
make it perceptually equivalent to a continuous resolution. The
noise was dynamic, spatiotemporally extended and presented
over the entire screen and visible at all times. The noise was
binary and elements were 2× 2 pixels wide (i.e., 0.028× 0.028◦).
Statistical Analysis
For the motion and orientation visual perception tests, mean
luminance/contrast threshold were analyzed using a Wilcoxon
test between the testings performed before and after the intake
of DPZ. The progression of the speed thresholds in the MOT
task was analyzed in each group separately using a Friedman test
with Bonferroni correction (p < 0.01) for multiple comparisons
of speed threshold values between the baseline (Week 1) and
the training weeks (Weeks 2–5). An additional comparison was
conducted to examine the difference in performance between
both groups (control and DPZ) using the Kruskal-Wallis
test to compare speed thresholds at each time point (Weeks
1–5). Long-term testing of the 3D-MOT speed threshold was
compared to the speed threshold of the first week (baseline)
from the returning participants using a Wilcoxon test. Statistical
analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL,
USA).
RESULTS
Donepezil Effect on 3D-MOT Training
The 3D-MOT task is a training task conducted over
five consecutive weeks during which participants gradually
improve their tracking performance. The subjects taking DPZ
were able to successfully track four balls with significantly greater
speed as early as the fourth session (p = 0.003) compared to
their baseline values (measured during the first session). This
result was maintained in the fifth session (p = 0.001; Figure 1).
In contrast, the control group only showed a significant
improvement in speed threshold during the fifth training
session (p = 0.002; Figure 1). However, the speed threshold for
which the subjects were able to track balls was not significantly
different between the DPZ and control group at any time point
(Kruskal-Wallis test, p > 0.05) although percentage of change
from baseline was 20%–50% higher for the DPZ group compared
to the placebo group for each session after week 3.
Donepezil Effect on the 3D-MOT Task is
Long-Lasting
Performance of the 3D-MOT task was also measured
4–14 months following the last testing session depending
on participant availability (Figures 1C,D). The average amount
of time between the last training session and the retesting
session was not significantly different between the two groups
(Kruskal-Wallis, p = 0.711). A significant increase in the speed
threshold (86%) obtained by the initial DPZ group was observed
at this late time point compared to baseline values (Week
1; Wilcoxon test, p = 0.043). The control group maintained
good tracking skills but the increase in speed threshold (45%)
compared to baseline values was not significant at that point
(Wilcoxon test, p = 0.068).
Acute Administration of Donepezil does
Not Affect First- and Second-Order Stimuli
Discrimination
To evaluate the acute effect of DPZ on basic visual processing,
motion and orientation discrimination abilities were tested
before and 3 h after DPZ administration. The motion
discrimination threshold was not affected by DPZ either
in terms of first-order stimuli (p = 0.878) or second-order
stimuli (p = 0.878; Figures 2B,C). Additionally, orientation
discrimination was not affected by DPZ for either first-
order stimuli (p = 0.515) or second-order stimuli (p = 0.386;
Figures 2B,C). Together these results suggest that acute
cholinergic potentiation does not influence basic visual
processing of orientation and motion. The fact that no difference
was observed for both levels of processing might be explained by
the lack of repetitive training/DPZ administration that could not
induce an optimal recruitment of cholinergic neurons or by an
optimal performance of the young subjects, which might not be
further increased.
DISCUSSION
This study demonstrates that an increase in cholinergic
transmission by the AChEIs, DPZ, has no significant effect on
the tracking skills in the 3D-MOT task compared to placebo but
may improve the learning in this 5-week perceptual-cognitive
training procedure (1 session/week). In addition, preliminary
results suggest that the training effect was maintained after
4–14 months in the DPZ group but not in the control group.
This long-term result is preliminary, due to the small sample
of returning participants. The basic visual discrimination of
first- or second-order stimuli did not seem to be affected by
cholinergic potentiation as measured in an additional one-time,
pre-post drug study without placebo control. Together, these
results suggest the role of the cholinergic system in fine-tuning
complex visual perceptual-cognitive processing. The discussion
emphasizes how this DPZ effect might be due to the role of
ACh in attentional processes, optimization of visual efficiency
(refining of cortical circuitry and increase in sustained neural
firing), improvement of the signal/noise ratio, repetitive training,
or all these effects combined.
Cholinergic Enhancement Improves
Training but Not Performance in a
Multi-Focal Attention Task in Healthy
Young Adults
The present results showed that DPZ facilitates the learning
in a 5-week multi-focal attention 3D-MOT training procedure.
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The overall maximum performance measured at the fifth
session was however not significantly improved by DPZ
administration, suggesting a learning effect rather than an
improvement of performance per se. This learning effect
could be due to a potentiation of the attentional capacities
by increased brain concentrations of ACh. This result is in
line with previous studies showing that ACh is involved in
visual attention processes in primates (Voytko et al., 1994;
Bentley et al., 2004; Herrero et al., 2008) and that DPZ
potentiates performance in attentional tasks (Rokem et al.,
2010). As well, the cholinergic enhancement by physostigmine
(another cholinesterase inhibitor) potentiates selective attention
by improving selectivity to the relevant stimuli (Furey et al.,
2000; Ricciardi et al., 2009). In the 3D-MOT task, both selective
and divided attention are involved (Cavanagh and Alvarez, 2005;
Doran and Hoffman, 2010) and could be potentiated by a higher
ACh concentration.
The learning effect of DPZ on 3D-MOT training could also
be due to a refinement of the cortical circuitry sustaining the
accomplishment of the task. 3D-MOT training increases by itself
attention, working memory and visual information processing
speed. Moreover, 3D-MOT training induces changes in resting-
state functional brain imaging and electroencephalography,
more specifically a decrease in the theta, alpha and gamma
frequencies in the frontal lobe and increased gamma frequency
over the occipital lobes (Parsons et al., 2016). It has been
established that cholinergic activity during top-down attention
processes also influences interactions between the different
brain areas (Golmayo et al., 2003; Nelson et al., 2005). For
instance, the improvement in working memory performance
following a steady-state infusion of the AChEI physostigmine
was accompanied by increased activity in the visual cortex
associated with perceptual processing, whereas activity in the
prefrontal cortex was decreased, suggesting a reduction of
attentional load to perform the same task (Furey et al., 2000).
ACh also plays a role in reducing the spatial spread of
visual responses in early visual cortex tested in fMRI (Silver
et al., 2008). Given that 3D-MOT is a task that requires
higher levels of processing (Faubert and Sidebottom, 2012) and
involves multiple brain areas (Culham et al., 1998; Jovicich
et al., 2001), coupling this task with cholinergic enhancement
benefits from the role of the cholinergic system in increasing
the activation of the sensory cortex and the refinement of
processing. Improvement of the 3D-MOT performance by
regional activation has also been shown by transcranial current
brain stimulation of certain structures (anterior intraparietal
sulcus, for example) in the visual pathway (Blumberg et al.,
2015).
An additional role of cholinergic potentiation in faster
improvement of tracking skill of participants is the possible
modulation of the signal-to-noise ratio, thus making relevant
stimuli sharper. Some studies demonstrate that ACh can increase
the processing of relevant stimuli and suppress the processing
of irrelevant input in a top-down attention task. Human studies
show that ACh allows a clearer perceptual representation of
the target by reducing background noise (Furey et al., 2000;
Ricciardi et al., 2009). In rats, cholinergic enhancement is
associated with an improvement in the signal-to-noise ratio
therefore enhancing the rat’s response to a visual stimulus (Kang
et al., 2014a). Therefore, administering DPZ could have had
an effect in reducing the noise level, allowing the participants
to have a clearer representation of the targets among the
distractors.
3D-MOT performance usually improves during training
because of specific perceptual-cognitive learning activity
(Makovski et al., 2008). Given the role of ACh in learning,
pairing visual training with ACh enhancement may modulate
the tuning of the neurons for the trained stimuli (Rokem
and Silver, 2010). In fact, studies in rats and humans have
shown the role of cholinergic enhancement of visual training
on the potentiation of visual capacities such as visual cortical
responsiveness (Kang et al., 2014a; Chamoun et al., 2016),
contrast sensitivity (Soma et al., 2013; Boucart et al., 2015),
motion direction discrimination (Rokem and Silver, 2010) and
texture discrimination (Beer et al., 2013). In addition, given
the role of the cholinergic system in attention and the role of
attention in perceptual learning (Ahissar and Hochstein, 1993),
pairing visual training with ACh enhancement may fine-tune
the allocation of attention in this multi-focal attention task.
Therefore, perceptual-cognitive learning combined with DPZ
administration might optimize multi-focal tracking skills. The
lack of effect of DPZ on the absolute performance value could
be indicative of a ceiling effect due to high performance and
cholinergic activity in young healthy subjects preventing further
improvement of performance.
The Cholinergic Enhancement Effect Is
Long-Lasting
The present study suggests that cholinergic enhancement has
a long-lasting effect on tracking performance. However, the
long-term effect was tested on a smaller sample of participants
(n = 9) and further studies need to be conducted to verify such
an effect. This lasting effect would correspond with previous
studies showing that an improvement in visual learning after
training on a motion task lasts for months after the training
(Ball and Sekuler, 1982). However, the cholinergic enhancement
doubled the amount of learning compared to the control subjects
at this time point, suggesting that the cholinergic effect on visual
learning and consolidation of the learning or recall mechanism
(Zaninotto et al., 2009) amplifies retention of performance skills.
Likewise, in a previous study, participants were trained on a
texture discrimination task and were given an ACh agonist
(nicotine) at the end of the training session, indicating an effect of
ACh on consolidation processes (Beer et al., 2013). The present
results indicate that an effect of AChEI on the consolidation
of learning of a trained task is possible. In animal models,
long-term potentiation-like effects of the cholinergic system have
been observed on visual evoked potentials after basal forebrain
stimulation (Kang et al., 2014a), suggesting the formation of
memory traces in the visual cortex. Together these findings
suggest a role of cholinergic enhancement in the encoding
and long-term perceptual-cognitive learning processes following
visual training.
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Limitation of the Study
This study was conducted with a relatively small sample of
participants, reducing the power of the statistical analysis. While
this sample size is regularly used in corresponding studies, we
obviously need a greater sample size to more thoroughly assess
possible effects of DPZ on the performance level in the 3D-MOT
task. Also, the long-term data are for a smaller number of
returning participants and should be further confirmed. Further
experiments will also be required to isolate the transfer effects
of this cholinergic potentiation on attention or perception.
However, it is known that 3D-MOT training over 5 weeks can
enhance cognition and changes in resting-state neuroelectric
brain function (Parsons et al., 2016).
CONCLUSION
In conclusion, repetitive DPZ administration during perceptual-
cognitive training led to an earlier improvement of tracking
ability and to a potential long-lasting effect. We believe that this
effect is due to a combination of the effect of ACh on attention,
perception and fine tuning of visual processing. These results
suggest the importance of boosting the cholinergic system in
practicing visual tasks to enhance plastic changes and efficacy
of visual processing and memory traces. This effect would help
in improving rehabilitation strategies to help visually impaired
people recover vision capacity.
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